Case Comprehensive Cancer Center earns ‘exceptional’ rating, $31.9 million in grants for research and education from National Cancer Institute

Collaboration across Case Western Reserve University, Cleveland Clinic and University Hospitals celebrates 30th anniversary as one of nation’s elite cancer centers

Northeast Ohio’s coordinated effort to combat cancer has earned an extraordinary endorsement from the National Cancer Institute (NCI): its highest-possible rating and $31.9 million to continue its lifesaving work.

The rating of “exceptional” comes as the Case Comprehensive Cancer Center–a collaboration among Case Western Reserve University, Cleveland Clinic and University Hospitals–celebrates its 30th anniversary of improving cancer outcomes through scientific discovery.

The center is one of just 49 NCI-designated comprehensive cancer centers nationally, and one of a small handful to earn an exceptional rating after an exhaustive review of its programs, which involve more than 370 physicians and scientists across the three organizations. The NCI evaluates cancer centers every five years as part of its grant renewal process.

“This ‘exceptional’ rating reflects national recognition of the excellence of our 370 brilliant and dedicated center members,” President Barbara R. Snyder said, “as well as the inspiring progress they can make when they work together to defeat the common enemy that is cancer. We deeply appreciate the National Cancer Institute’s support in helping us find still more treatments and cures for this deadly and devastating disease.”

The NCI review recognized Stanton Gerson, the Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology at Case Western Reserve and the cancer center’s director since 2004, for his leadership and for developing such initiatives implementing a strategic-planning effort and enhanced transdisciplinary collaborations, establishing the Office of Cancer Disparities Research and recruiting talented new senior leaders and researchers.

The review also praised the center for continuing to be a research leader in basic, clinical and population sciences, and for providing exemplary service to the population in Northeast Ohio. The center has built a national reputation for research in colorectal cancers, leukemia and myelodysplastic syndrome (MDS), brain, lung, kidney and prostate cancers.

Combined, Cleveland Clinic and University Hospitals treat nearly 16,000 new cancer patients each year. Because these hospitals are part of an NCI-designated comprehensive cancer center, these patients have greater opportunities to participate in a broad range of clinical trials; they also benefit from the concentration of expertise among the three organizations.

“Coming together with the goal of driving research focused on the diagnosis, treatment, prevention and control of cancer demonstrates the impact that collaboration among our institutions can have,” said Cleveland Clinic CEO and President Tom Mihaljevic, M.D. “The collaboration furthers training and education; cancer research and clinical care; and support services that help patients and the communities we serve.”

Among the center’s recent achievements:

  • Sanford Markowitz and Amitabh Chak developed a balloon device that can be swallowed to detect Barrett’s Esophagus, a precursor to cancer, in an outpatient setting, without sedation. The device allows for quick, non-invasive diagnosis that can soon replace invasive endoscopy.
  • Monica Webb Hooper is leading a national cancer “moonshot” initiative on smoking cessation for cancer patients, first supported by CVS Health, and continues with support from NCI.
  • A team of researchers led by Vikas Gulani and Lee Ponsky evaluated Magnetic Resonance Fingerprinting to improve detection of prostate cancer in men.
  • Research conducted by Justin Lathia, Ph.D., and Ofer Reizes, Ph.D., on cancer stem cells could lead to promising new ways to treat triple-negative breast cancer when hormone therapy fails, and better predict patient health outcomes.
  • Anant Madabhushi and Vamsidhar Velcheti, M.D., are developing a computerized tissue-imaging program that could soon help identify which lung-cancer patients are likely to face an earlier recurrence of the disease, and figure out which patients will best respond to chemotherapy.
  • A new magnetic resonance imaging contrast agent being tested by Zheng-Rong Lu not only pinpoints breast cancers at early stages, but differentiates between aggressive and slow-growing types.
  • A team led by Paul Tesar developed a new method to screen brain-tumor cells and identify potential drug targets missed by traditional methods.
  • Colon cancer and MDS investigators, led by Kishore Guda and Jaroslaw Maciejewski, M.D., Ph.D., identified cancer gene mutations that occur with increased frequency in African-Americans that have poor prognosis.
  • Shideng Bao, Ph.D., found an FDA-approved drug for lymphoma and leukemia, ibrutinib, may be effective in slowing growth of glioblastoma, a deadly form of brain cancer.
  • Research conducted by Qing Yi, M.D., Ph.D., and his team shows that reducing cholesterol levels could enhance effectiveness of T-cell immunotherapy.
  • A team including Peter Scacheri, Alex Huang and Brian Rubin, M.D., Ph.D., has discovered a way to target genes to block metastasis in osteosarcoma, a common primary malignancy of the bone with peak incidence in children and adolescents.
  • Members have successfully discovered and developed novel molecules to translate the science of our members into clinical therapies. New therapeutic discoveries include three new drugs now in clinical trials, along with five novel cell therapies.

“We congratulate Dr. Stan Gerson on the successful renewal of the National Cancer Institute’s grant for the continuing support of the Case Comprehensive Cancer Center,” said Thomas F. Zenty III, CEO of University Hospitals.  “Through our partnership, University Hospitals and the Case Comprehensive Cancer Center offer the residents of Northeast Ohio access to innovative clinical trials that not only heal our patients, but advance the standard of cancer care nationally.”

As part of the review and designation, the NCI approved the renewal of a five-year, $27.9 million (P30) grant to support collaborative research.

The center was also lauded for its training, education and career-development programs for cancer trainees, from high school through junior faculty. Simultaneously, NCI awarded the center a $4 million (K-12) Paul Calabrese Clinical Oncology Scholar Training grant to support clinical investigators across the institutions. CWRU has the longest-running award of this type in the country.

“It is an honor to bring together the fantastic researchers, brilliant innovators and committed clinicians from across the academic institutions in Cleveland to focus on discoveries that improve the lives of cancer patients and their families,” Gerson said. “Our discoveries are moving at warp speed to benefit patients. The institutional support is remarkable, and was noted by our outside reviewers.”

The center has held an NCI designation since its founding by Case Western Reserve and University Hospitals, and attained “comprehensive” status in 1998. Cleveland Clinic formally joined the consortium in 2003.

About Cleveland Clinic

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. Among Cleveland Clinic’s 52,000 employees are more than 3,600 full-time salaried physicians and researchers and 14,000 nurses, representing 140 medical specialties and subspecialties. Cleveland Clinic’s health system includes a 165-acre main campus near downtown Cleveland, 11 regional hospitals, more than 150 northern Ohio outpatient locations – including 18 full-service family health centers and three health and wellness centers – and locations in Weston, Fla.; Las Vegas, Nev.; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2017, there were 7.6 million outpatient visits, 229,000 hospital admissions and 207,000 surgical cases throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 185 countries. Visit us at Follow us at News and resources available at

About Case Western Reserve University

Case Western Reserve University is one of the country's leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 5,100 undergraduate and 6,200 graduate students comprise our student body. Visit to see how Case Western Reserve thinks beyond the possible.

About University Hospitals / Cleveland, Ohio

Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 50 outpatient health centers and 200 physician offices in 15 counties throughout northern Ohio. The system’s flagship academic medical center, University Hospitals Cleveland Medical Center, located on a 35-acre campus in Cleveland’s University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development. UH is one of the largest employers in Northeast Ohio with 26,000 employees.

UH’s vision is “Advancing the science of health and the art of compassion,” and its mission: “To Heal. To Teach. To Discover.”  Follow UH on Facebook @UniversityHospitals and Twitter @UHhospitals. For more information, go to